Gavin joined the School of Life Sciences in 2021. He is a Cancer Biologist, with a broad research experience and interests that cover numerous aspects of cancer including development, invasion/migration, diagnosis, drug resistance and identification of novel drug targets.
Gavin completed his research training at Imperial College London, being awarded a Masters of Research in Oncology and Cancer Biology and a joint multidisciplinary PhD in Clinical Medicine and Biomedical Engineering. Whilst at Imperial, he developed a comprehensive knowledge of molecular oncology including cancer cell signalling pathways and diagnostics, as well as organic chemistry skills, including the design and development of novel fluorogenic biosensors.
Gavin also completed a postdoctoral research role at the Barts Cancer Institute, London. Research explored stem cell evolution and progression to cancer in disease states that predispose to adenocarcinoma, via histopathological means. Gavin has also previously been employed within the medical devices industry, the NHS, and the medical regulatory industry.
Gavin is an author on numerous peer-reviewed journals, and is also a Non-Executive Director for the leukodystrophy charity, Alex TLC.